Clinical Trials
9
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials
A Study of the Pharmacokinetics and Safety of CS0159 in Subjects With Hepatic Injury
- First Posted Date
- 2025-03-21
- Last Posted Date
- 2025-07-11
- Lead Sponsor
- Cascade Pharmaceuticals, Inc
- Target Recruit Count
- 24
- Registration Number
- NCT06888115
- Locations
- 🇨🇳
The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
🇨🇳The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
🇨🇳Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China
Study to Evaluate Safety, Tolerability and Pharmacokinetics of CS060380 in Healthy and Elevated LDL-C Subjects
- First Posted Date
- 2024-08-27
- Last Posted Date
- 2025-04-30
- Lead Sponsor
- Cascade Pharmaceuticals, Inc
- Target Recruit Count
- 104
- Registration Number
- NCT06573528
- Locations
- 🇨🇳
Shanghai Xuhui Central Hospital, Shanghai, China
Study to Evaluate Safety, Tolerability and Pharmacokinetics of CS060304 in Healthy and Elevated LDL-C Subjects
- First Posted Date
- 2024-07-03
- Last Posted Date
- 2025-02-26
- Lead Sponsor
- Cascade Pharmaceuticals, Inc
- Target Recruit Count
- 80
- Registration Number
- NCT06485245
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China
Study of [14C]CS0159 in China Healthy Subjects
- First Posted Date
- 2023-10-24
- Last Posted Date
- 2023-11-21
- Lead Sponsor
- Cascade Pharmaceuticals, Inc
- Target Recruit Count
- 6
- Registration Number
- NCT06098027
- Locations
- 🇨🇳
The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
CS0159 in Chinese Patients With PBC (Primary Biliary Cholangitis)
- Conditions
- Primary Biliary Cholangitis (PBC)
- Interventions
- Drug: 2mg CS0159Drug: Placebo
- First Posted Date
- 2023-06-09
- Last Posted Date
- 2024-11-19
- Lead Sponsor
- Cascade Pharmaceuticals, Inc
- Target Recruit Count
- 75
- Registration Number
- NCT05896124
- Locations
- 🇨🇳
The First Affiliated Hospital of USTC Anhui Provincial Hospital, Hefei, Anhui, China
🇨🇳Beijing Friendship Hospital, Captail Medcial University, Beijing, Beijing, China
🇨🇳Beijing Youan Hostital, Captial Medical University, Beijing, Beijing, China
- Prev
- 1
- 2
- Next